Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 145 publications
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents.
Journal: American journal of hematology
Published: May 06, 2026
Redefining hemophilia management: treatment goals, nonfactor replacement therapies, and the role of fitusiran.
Journal: The American journal of managed care
Published: January 21, 2026
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B.
Journal: The New England journal of medicine
Published: December 08, 2025
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial.
Journal: Research and practice in thrombosis and haemostasis
Published: November 03, 2025
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results.
Journal: Research and practice in thrombosis and haemostasis
Published: October 02, 2025
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 09, 2025
Characterization of the clinical and laboratory phenotype of hemophilia carriers and trends of utilization of hemostatic therapies: analysis of the American Thrombosis and Hemostasis Network dataset.
Journal: Research and practice in thrombosis and haemostasis
Published: April 03, 2025
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.
Journal: Research and practice in thrombosis and haemostasis
Published: March 04, 2025
Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.
Journal: Molecular therapy. Methods & clinical development
Published: February 10, 2025
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 05, 2025
Guidelines for management of hemophilia-why, what, and how?
Journal: Research and practice in thrombosis and haemostasis
Published: February 02, 2025
Pain Reduction Following Eptacog Beta Treatment of Bleeding Episodes in Adolescents and Adults With Haemophilia A or B Complicated by Inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 08, 2025
Last Updated: 09/26/2026